Gilead reaffirms 2018 sales outlook $20B-$21B, consensus $21.29B
Reaffirms 2018 Product Gross Margin outlook 85%-87%. The company still sees the diluted EPS impact of acquisition-related, up-front collaboration, stock-based compensation and other expenses at $1.41 – $1.51 .
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.